Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer
January 02, 2024 08:30 ET
|
Daxor Corporation
The New BVA System is Designed to be Significantly Faster, Simpler and Give Results at the Bedside Oak Ridge, TN, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global...
Daxor Corporation Awarded $305K Grant from the National Institutes of Health to Develop Blood Volume Guidance Software in Sepsis Patients
September 11, 2023 12:00 ET
|
Daxor Corporation
Oak Ridge, TN, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announced that the National Institutes of Health...
Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering
May 25, 2023 15:37 ET
|
Daxor Corporation
Oak Ridge, TN, May 25, 2023 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the closing of...
New Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomes
May 18, 2023 08:00 ET
|
Daxor Corporation
Daxor’s BVA Technology Shown to Provide Unique and Individualized Data for Patient Management Oak Ridge, TN, May 18, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader...
Daxor’s Blood Volume (BVA-100®) Diagnostic Demonstrates Clinical Utility In Critically-Ill COVID-19 Patients In Newly Published Data in Journal Critical Care
August 04, 2021 08:30 ET
|
Daxor Corporation
Data Led to Multi-Center Study In Progress At Three Leading Hospitals Oak Ridge, TN, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume...
New Data Presented on Blood Volume at Annual Heart Failure Society Meeting Amid Call to Broadly Adopt Daxor’s Diagnostic Technology
September 18, 2019 08:00 ET
|
Daxor Corporation
NEW YORK, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation to Present at the LD Micro 9th Annual Invitational on June 4th, 2019
May 31, 2019 08:00 ET
|
Daxor Corporation
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 48th Congress
February 13, 2019 08:30 ET
|
Daxor Corporation
New Research Abstracts Scheduled for Presentation on Daxor’s BVA-100® NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical...
Newly Published Data Show Daxor Corporation's BVA-100 Is Superior To Formula-Based Estimates of Blood Volume In Assessing Patients With Heart Failure
August 20, 2018 08:30 ET
|
Daxor Corporation
NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces the...